<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT00141466</url>
  </required_header>
  <id_info>
    <org_study_id>MIPA-2005</org_study_id>
    <secondary_id>ZonMw nr. 945-14-107</secondary_id>
    <nct_id>NCT00141466</nct_id>
  </id_info>
  <brief_title>Implementation of a New Strategy to Identify HNPCC Patients</brief_title>
  <official_title>Cost Effectiveness of Two Different Implementation Procedures to Change Clinicians Practice Roles in the Detection of Hereditary Colorectal Cancer</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Radboud University</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
    <collaborator>
      <agency>ZonMw: The Netherlands Organisation for Health Research and Development</agency>
      <agency_class>Other</agency_class>
    </collaborator>
  </sponsors>
  <source>Radboud University</source>
  <brief_summary>
    <textblock>
      The purpose of this study is to compare two different strategies to implement a new method to
      identify patients with HNPCC, which appeared cost-effective and feasible. The effectiveness,
      costs and feasibility of both of the implementation strategies will be assessed.
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      The Radboud University Nijmegen Medical Centre developed a new method to identify patients
      with HNPCC. This method appeared cost-effective and feasible. Using this new method 70% of
      the HNPCC patients will be identified as compared to less than 30% when the current method is
      used. However, this new method does not implement itself; large gaps exists between best
      evidence and daily practice. This study will compare an intensive strategy, consisting of
      distribution of educational materials, education, feedback and reminders, with a minimal
      strategy, only consisting of distribution of a critical care pathway. The aim is to find the
      most cost-effective strategy to implement the new method to identify patients with HNPCC in
      the Netherlands.
    </textblock>
  </detailed_description>
  <overall_status>Unknown status</overall_status>
  <last_known_status>Recruiting</last_known_status>
  <start_date>September 2005</start_date>
  <completion_date type="Anticipated">July 2007</completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <masking>Single</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Efficacy of inclusion of eligible CRC-patients for MSI testing by pathologists.</measure>
  </primary_outcome>
  <primary_outcome>
    <measure>Efficacy of referral of patients who are MSI positive to a clinical geneticist by surgeons.</measure>
  </primary_outcome>
  <secondary_outcome>
    <measure>Experiences with and acceptance of changed physician practice roles by patients and clinicians.</measure>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Cost efficacy of the implementation procedures.</measure>
  </secondary_outcome>
  <enrollment type="Anticipated">360</enrollment>
  <condition>Colorectal Neoplasms</condition>
  <condition>Hereditary Nonpolyposis Colorectal Cancer</condition>
  <intervention>
    <intervention_type>Behavioral</intervention_type>
    <intervention_name>Education for professionals</intervention_name>
  </intervention>
  <intervention>
    <intervention_type>Behavioral</intervention_type>
    <intervention_name>Distribution of educational materials</intervention_name>
  </intervention>
  <intervention>
    <intervention_type>Behavioral</intervention_type>
    <intervention_name>Feedback for professionals</intervention_name>
  </intervention>
  <intervention>
    <intervention_type>Behavioral</intervention_type>
    <intervention_name>Reminders for professionals</intervention_name>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  Colorectal cancer before the age of 50 years

          -  Second colorectal cancer at any age

          -  Colorectal cancer and other HNPCC associated extracolonic cancer irrespective of age
             at diagnosis

          -  Adenoma with high grade dysplasia diagnosed before the age of 40 years
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>N/A</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Nicoline Hoogerbrugge, MD PhD</last_name>
    <role>Principal Investigator</role>
    <affiliation>Department of Human Genetics, Radboud University Nijmegen Medical Center</affiliation>
  </overall_official>
  <overall_official>
    <last_name>Rosella P Hermens, MSc PhD</last_name>
    <role>Principal Investigator</role>
    <affiliation>Center of Quality of Care Research, Radboud University Nijmegen Medical Center</affiliation>
  </overall_official>
  <overall_contact>
    <last_name>Lucy I Overbeek, MSc</last_name>
    <phone>+31-24-3613946</phone>
    <email>l.overbeek@antrg.umcn.nl</email>
  </overall_contact>
  <overall_contact_backup>
    <last_name>Nicoline Hoogerbrugge, MD PhD</last_name>
    <phone>+31-24-3613946</phone>
    <email>n.hoogerbrugge@antrg.umcn.nl</email>
  </overall_contact_backup>
  <location>
    <facility>
      <name>Jeroen Bosch Ziekenhuis</name>
      <address>
        <city>'s-Hertogenbosch</city>
        <country>Netherlands</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Stan J Ketelaars, MD</last_name>
    </contact>
  </location>
  <location>
    <facility>
      <name>Meander Medisch Centrum</name>
      <address>
        <city>Amersfoort</city>
        <country>Netherlands</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Els JM Ahsmann, MD PhD</last_name>
    </contact>
  </location>
  <location>
    <facility>
      <name>Ziekenhuis Rijnstate</name>
      <address>
        <city>Arnhem</city>
        <country>Netherlands</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Jos Meijer, MD</last_name>
    </contact>
  </location>
  <location>
    <facility>
      <name>HagaZiekenhuis</name>
      <address>
        <city>Den Haag</city>
        <country>Netherlands</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Paul Blok, MD PhD</last_name>
    </contact>
  </location>
  <location>
    <facility>
      <name>Pathologie laboratorium voor Dordrecht</name>
      <address>
        <city>Dordrecht</city>
        <country>Netherlands</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Pieter J Westenend, MD PhD</last_name>
    </contact>
  </location>
  <location>
    <facility>
      <name>Stichting laboratoria voor pathologische anatomie en medische microbiologie</name>
      <address>
        <city>Eindhoven</city>
        <country>Netherlands</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Ineke van Lijnschoten, MD PhD</last_name>
    </contact>
  </location>
  <location>
    <facility>
      <name>Laboratorium voor pathologie Oost-Nederland</name>
      <address>
        <city>Enschede</city>
        <country>Netherlands</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Sietske Riemersma, MD</last_name>
    </contact>
  </location>
  <location>
    <facility>
      <name>Martini Ziekenhuis</name>
      <address>
        <city>Groningen</city>
        <country>Netherlands</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Ton Tiebosch, MD PhD</last_name>
    </contact>
  </location>
  <location>
    <facility>
      <name>Elkerliek Ziekenhuis</name>
      <address>
        <city>Helmond</city>
        <country>Netherlands</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Cilia M Ferrier, MD PhD</last_name>
    </contact>
  </location>
  <location>
    <facility>
      <name>Laboratorium Volksgezondheid Friesland</name>
      <address>
        <city>Leeuwarden</city>
        <country>Netherlands</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Joris J Grond, MD PhD</last_name>
    </contact>
  </location>
  <location>
    <facility>
      <name>Canisius Wilhelmina Ziekenhuis</name>
      <address>
        <city>Nijmegen</city>
        <country>Netherlands</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Erik Thunnissen, MD PhD</last_name>
    </contact>
  </location>
  <location>
    <facility>
      <name>Medisch Centrum Rijnmond Zuid</name>
      <address>
        <city>Rotterdam</city>
        <country>Netherlands</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Sonja Henzen, MD PhD</last_name>
    </contact>
  </location>
  <location>
    <facility>
      <name>St. Elisabeth Ziekenhuis</name>
      <address>
        <city>Tilburg</city>
        <country>Netherlands</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Anneke van der Wurff, MD PhD</last_name>
    </contact>
  </location>
  <location_countries>
    <country>Netherlands</country>
  </location_countries>
  <reference>
    <citation>Kievit W, de Bruin JH, Adang EM, Severens JL, Kleibeuker JH, Sijmons RH, Ruers TJ, Nagengast FM, Vasen HF, van Krieken JH, Ligtenberg MJ, Hoogerbrugge N. Cost effectiveness of a new strategy to identify HNPCC patients. Gut. 2005 Jan;54(1):97-102.</citation>
    <PMID>15591512</PMID>
  </reference>
  <reference>
    <citation>de Bruin JH, Kievit W, Ligtenberg MJ, Nagengast FM, Adang EM, Ruers TJ, Kleibeuker JH, Sijmons RH, van Krieken JH, Hoogerbrugge N. [More hereditary intestinal cancer can be detected if patients with colorectal carcinoma that are selected by the pathologist are examined for microsatellite instability]. Ned Tijdschr Geneeskd. 2005 Aug 6;149(32):1792-8. Dutch.</citation>
    <PMID>16121665</PMID>
  </reference>
  <verification_date>February 2007</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>August 31, 2005</study_first_submitted>
  <study_first_submitted_qc>August 31, 2005</study_first_submitted_qc>
  <study_first_posted type="Estimate">September 1, 2005</study_first_posted>
  <last_update_submitted>April 22, 2008</last_update_submitted>
  <last_update_submitted_qc>April 22, 2008</last_update_submitted_qc>
  <last_update_posted type="Estimate">April 23, 2008</last_update_posted>
  <keyword>Hereditary colorectal cancer</keyword>
  <keyword>Microsatellite instability</keyword>
  <keyword>Physician roles</keyword>
  <keyword>Health care implementation</keyword>
  <keyword>Intervention</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Colorectal Neoplasms</mesh_term>
    <mesh_term>Colorectal Neoplasms, Hereditary Nonpolyposis</mesh_term>
  </condition_browse>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

